Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of secondary adrenal insufficiency after severe traumatic brain injury
2010-019178-33Phase 3Active
- Sponsor
- CHU de Nantes
- Start
- Apr 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone and fludrocortisone in Adrenocorticotropic hormone, sponsored by CHU de Nantes. Primary endpoint: Nosocomial pneumonia at day 28. Started Apr 2010; status: active.
02
Drugs
hydrocortisonefludrocortisone
03
Conditions
Adrenocorticotropic hormone
Beyond the preview
Go deeper on 2010-019178-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019178-33.